好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Long-Term Safety and Maintenance of Efficacy From an Open-Label Extension of the Double-Blind Pivotal Study of Levodopa-Carbidopa Intestinal Gel (LCIG) in Advanced Parkinson's Disease Patients
Movement Disorders
(-)
081
Authors/Disclosures
Hubert H. Fernandez, MD, FAAN (Center for Neurological Restoration, Cleveland Clinic)
PRESENTER
Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Gorana Capkun No disclosure on file
No disclosure on file
John T. Slevin, MD, FAAN (University of Kentucky) The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
No disclosure on file
Susan A. Eaton, PharmD (AbbVie) No disclosure on file
Jordan S. Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio .
Krai Chatamra, PhD (InTrance Medical Systems) No disclosure on file
Janet Benesh, BSMT (Abbott Laboratories) No disclosure on file